Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease

NCT00074932 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Glycogen Storage Disease Type II
Glycogenosis 2

Interventions

BIOLOGICAL: Myozyme

Sponsor

Genzyme, a Sanofi Company